CytomX Therapeutics (CTMX) Stock Price & Financial Analysis
CytomX Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About CytomX Therapeutics
What is the current stock price for CTMX?
As of the latest trading session, CTMX stock trades at $3.54. The 52-week range is $1.90–$8.21, with a day range of $3.50–$3.66.
What is the P/E ratio for CTMX?
The P/E ratio (Price-to-Earnings) for CTMX is shown in the Key Statistics section. This valuation metric helps compare CytomX Therapeutics, Inc. to industry peers.
Does CTMX pay dividends?
CytomX Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CTMX?
Analyst ratings and recommendations for CTMX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CTMX?
CytomX Therapeutics's market capitalization is $627.5M, classifying it as a small-cap company. CytomX Therapeutics operates in the Healthcare sector within the Biotechnology industry.